BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 20138935)

  • 61. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
    Chen CH; Lin YS; Wu SJ; Mi FL
    Carbohydr Polym; 2018 Aug; 193():163-172. PubMed ID: 29773368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
    Verma A; Sharma S; Gupta PK; Singh A; Teja BV; Dwivedi P; Gupta GK; Trivedi R; Mishra PR
    Acta Biomater; 2016 Feb; 31():288-300. PubMed ID: 26685755
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery.
    Prego C; Fabre M; Torres D; Alonso MJ
    Pharm Res; 2006 Mar; 23(3):549-56. PubMed ID: 16525861
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spermined dextran, a cationized polymer, as absorption enhancer for pulmonary application of peptide drugs.
    Morimoto K; Fukushi N; Chono S; Seki T; Tabata Y
    Pharmazie; 2008 Mar; 63(3):180-4. PubMed ID: 18444505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats.
    Maeda T; Miyazono Y; Ito K; Hamada K; Sekine S; Horie T
    Cancer Chemother Pharmacol; 2010 May; 65(6):1117-23. PubMed ID: 19756603
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
    Kamei N; Morishita M; Ehara J; Takayama K
    J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
    Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
    Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of Intestinal Concentration and Colloidal Structure on the Permeation-Enhancing Efficiency of Sodium Caprate in the Rat.
    Berg S; Kärrberg L; Suljovic D; Seeliger F; Söderberg M; Perez-Alcazar M; Van Zuydam N; Abrahamsson B; Hugerth AM; Davies N; Bergström CAS
    Mol Pharm; 2022 Jan; 19(1):200-212. PubMed ID: 34928160
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
    Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
    J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and in vitro characterization of a novel PAA-ATP conjugate.
    Hoyer H; Hombach J; Perera G; Thaurer M; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2011 Mar; 37(3):300-9. PubMed ID: 20923387
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in protein and mRNA expression levels of claudin family after mucosal lesion by intestinal ischemia/reperfusion.
    Takizawa Y; Kishimoto H; Kitazato T; Tomita M; Hayashi M
    Int J Pharm; 2012 Apr; 426(1-2):82-89. PubMed ID: 22285474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
    Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
    Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of glutathione in the permeation enhancing effect of thiolated polymers.
    Clausen AE; Kast CE; Bernkop-Schnürch A
    Pharm Res; 2002 May; 19(5):602-8. PubMed ID: 12069161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers.
    Dorkoosh FA; Setyaningsih D; Borchard G; Rafiee-Tehrani M; Verhoef JC; Junginger HE
    Int J Pharm; 2002 Jul; 241(1):35-45. PubMed ID: 12086719
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of nanoparticulate drug delivery systems based on thiolated poly(acrylic acid).
    Thaurer MH; Deutel B; Schlocker W; Bernkop-Schnürch A
    J Microencapsul; 2009 May; 26(3):187-94. PubMed ID: 18946801
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HEC-cysteamine conjugates: influence of degree of thiolation on efflux pump inhibitory and permeation enhancing properties.
    Rahmat D; Sakloetsakun D; Shahnaz G; Sarti F; Laffleur F; Schnürch AB
    Int J Pharm; 2012 Jan; 422(1-2):40-6. PubMed ID: 22027393
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat.
    Yan C; Gu J; Lv Y; Shi W; Jing H
    Drug Deliv Transl Res; 2017 Jun; 7(3):408-415. PubMed ID: 28303451
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combining Chemical Permeation Enhancers for Synergistic Effects.
    du Toit T; Malan MM; Lemmer HJ; Gouws C; Aucamp ME; Breytenbach WJ; Hamman JH
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):575-86. PubMed ID: 25939330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.